Cargando…
Moyamoya disease with Sjogren disease and autoimmune thyroiditis presenting with left intracranial hemorrhage after messenger RNA-1273 vaccination: A case report
RATIONALE: The new vaccines are emergently authorized and currently approved for use to protect against the coronavirus disease 2019 (COVID-19) pandemic and serious adverse events are uncommon. Moyamoya disease (MMD) with autoimmune disease is a rare entity and usually presents with intracranial hem...
Autores principales: | Lin, Yi-Hsin, Huang, Hsuan, Hwang, Wen-Zern |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830843/ https://www.ncbi.nlm.nih.gov/pubmed/35147099 http://dx.doi.org/10.1097/MD.0000000000028756 |
Ejemplares similares
-
Case report: Moyamoya disease, the culprit in an adult female presenting with left sided numbness
por: Almutairi, Ohood Kh., et al.
Publicado: (2022) -
Posterior reversible encephalopathy syndrome (PRES) in a patient with moyamoya disease: A case report
por: Teng, Chun-Hsin, et al.
Publicado: (2021) -
(1)H-NMR-Based Metabolomic Analysis of Cerebrospinal Fluid From Adult Bilateral Moyamoya Disease: Comparison With Unilateral Moyamoya Disease and Atherosclerotic Stenosis
por: Jeon, Jin Pyeong, et al.
Publicado: (2015) -
Safety and effects of endovascular treatment of basilar tip aneurysms in patients with moyamoya diseases
por: Chen, Chun-Guang, et al.
Publicado: (2023) -
Clinical significance of asymmetric venous vasculature on minimum-intensity projection in patients with moyamoya disease
por: Han, Min Jeong, et al.
Publicado: (2022)